de Invesco Sabra Healthcare REIT SBRA Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 49.4 M | Comprar |
2,532,046
+210,907
| +9% | +USD 4.18 M | ﹤0.01% | 1118 |
|
|
2026
Q1 | USD 44.6 M | Comprar |
2,321,139
+20,378
| +0.9% | +USD 401 k | ﹤0.01% | 1117 |
|
|
2025
Q4 | USD 43.6 M | Vender |
2,300,761
-155,369
| -6% | -USD 2.88 M | ﹤0.01% | 1136 |
|
|
2025
Q3 | USD 45.8 M | Comprar |
2,456,130
+101,745
| +4% | +USD 1.9 M | 0.01% | 1117 |
|
|
2025
Q2 | USD 43.4 M | Vender |
2,354,385
-174,459
| -7% | -USD 3.1 M | 0.01% | 1105 |
|
|
2025
Q1 | USD 44.2 M | Vender |
2,528,844
-27,374
| -1% | -USD 462 k | 0.01% | 1087 |
|
|
2024
Q4 | USD 44.3 M | Comprar |
2,556,218
+229,708
| +10% | +USD 4.19 M | 0.01% | 1103 |
|
|
2024
Q3 | USD 43.3 M | Comprar |
2,326,510
+1,240,923
| +114% | +USD 20.9 M | 0.01% | 1105 |
|
|
2024
Q2 | USD 16.7 M | Vender |
1,085,587
-65,140
| -6% | -USD 931 k | ﹤0.01% | 1506 |
|
|
2024
Q1 | USD 17 M | Comprar |
1,150,727
+22,549
| +2% | +USD 312 k | ﹤0.01% | 1531 |
|
|
2023
Q4 | USD 16.1 M | Vender |
1,128,178
-199,212
| -15% | -USD 2.83 M | ﹤0.01% | 1532 |
|
|
2023
Q3 | USD 18.5 M | Vender |
1,327,390
-10,253
| -0.8% | -USD 131 k | 0.01% | 1373 |
|
|
2023
Q2 | USD 15.7 M | Vender |
1,337,643
-320,158
| -19% | -USD 3.64 M | ﹤0.01% | 1503 |
|
|
2023
Q1 | USD 19.1 M | Comprar |
1,657,801
+103,209
| +7% | +USD 1.28 M | 0.01% | 1380 |
|
|
2022
Q4 | USD 19.3 M | Vender |
1,554,592
-1,288,759
| -45% | -USD 16.4 M | 0.01% | 1395 |
|
|
2022
Q3 | USD 37.3 M | Vender |
2,843,351
-30,551
| -1% | -USD 451 k | 0.01% | 1005 |
|
|
2022
Q2 | USD 40.1 M | Comprar |
2,873,902
+140,932
| +5% | +USD 1.88 M | 0.01% | 1018 |
|
|
2022
Q1 | USD 40.7 M | Comprar |
2,732,970
+1,017,252
| +59% | +USD 13.9 M | 0.01% | 1088 |
|
|
2021
Q4 | USD 23.2 M | Vender |
1,715,718
-18,964
| -1% | -USD 268 k | 0.01% | 1459 |
|
|
2021
Q3 | USD 25.5 M | Comprar |
1,734,682
+397,466
| +30% | +USD 6.71 M | 0.01% | 1418 |
|
|
2021
Q2 | USD 24.3 M | Comprar |
1,337,216
+184,028
| +16% | +USD 3.28 M | 0.01% | 1479 |
|
|
2021
Q1 | USD 20 M | Comprar |
1,153,188
+318,687
| +38% | +USD 5.6 M | 0.01% | 1542 |
|
|
2020
Q4 | USD 14.5 M | Vender |
834,501
-2,038,038
| -71% | -USD 32.5 M | ﹤0.01% | 1607 |
|
|
2020
Q3 | USD 39.6 M | Comprar |
2,872,539
+1,820,806
| +173% | +USD 26.7 M | 0.01% | 1025 |
|
|
2020
Q2 | USD 15.2 M | Vender |
1,051,733
-1,215,790
| -54% | -USD 16 M | 0.01% | 1402 |
|
|
2020
Q1 | USD 24.8 M | Comprar |
2,267,523
+1,712,989
| +309% | +USD 31.6 M | 0.01% | 1107 |
|
|
2019
Q4 | USD 11.8 M | Vender |
554,534
-61,959
| -10% | -USD 1.39 M | ﹤0.01% | 1667 |
|
|
2019
Q3 | USD 14.2 M | Vender |
616,493
-435,536
| -41% | -USD 9.29 M | ﹤0.01% | 1581 |
|
|
2019
Q2 | USD 20.7 M | Comprar |
1,052,029
+138,557
| +15% | +USD 2.7 M | 0.01% | 1413 |
|
|
2019
Q1 | USD 17.8 M | Vender |
913,472
-19,304
| -2% | -USD 366 k | 0.01% | 1288 |
|
|
2018
Q4 | USD 15.4 M | Vender |
932,776
-40,691
| -4% | -USD 819 k | 0.01% | 1276 |
|
|
2018
Q3 | USD 22.5 M | Comprar |
973,467
+13,851
| +1% | +USD 314 k | 0.01% | 1209 |
|
|
2018
Q2 | USD 20.9 M | Vender |
959,616
-157,401
| -14% | -USD 3.07 M | 0.01% | 1219 |
|
|
2018
Q1 | USD 19.7 M | Comprar |
1,117,017
+32,946
| +3% | +USD 581 k | 0.01% | 1173 |
|
|
2017
Q4 | USD 20.3 M | Comprar |
1,084,071
+336,796
| +45% | +USD 6.7 M | 0.01% | 1204 |
|
|
2017
Q3 | USD 16.4 M | Comprar |
747,275
+82,025
| +12% | +USD 1.85 M | 0.01% | 1290 |
|
|
2017
Q2 | USD 16 M | Comprar |
665,250
+178,360
| +37% | +USD 4.54 M | 0.01% | 1292 |
|
|
2017
Q1 | USD 13.6 M | Vender |
486,890
-19,150
| -4% | -USD 502 k | ﹤0.01% | 1371 |
|
|
2016
Q4 | USD 12.4 M | Vender |
506,040
-7,092
| -1% | -USD 163 k | ﹤0.01% | 1402 |
|
|
2016
Q3 | USD 12.9 M | Comprar |
513,132
+78,038
| +18% | +USD 1.87 M | ﹤0.01% | 1346 |
|
|
2016
Q2 | USD 8.98 M | Comprar |
435,094
+77,878
| +22% | +USD 1.62 M | ﹤0.01% | 1497 |
|
|
2016
Q1 | USD 7.18 M | Vender |
357,216
-17,737
| -5% | -USD 340 k | ﹤0.01% | 1597 |
|
|
2015
Q4 | USD 7.58 M | Comprar |
374,953
+69,362
| +23% | +USD 1.46 M | ﹤0.01% | 1615 |
|
|
2015
Q3 | USD 7.08 M | Comprar |
305,591
+38,147
| +14% | +USD 973 k | ﹤0.01% | 1631 |
|
|
2015
Q2 | USD 6.88 M | Comprar |
267,444
+21,314
| +9% | +USD 605 k | ﹤0.01% | 1755 |
|
|
2015
Q1 | USD 8.16 M | Vender |
246,130
-14,857
| -6% | -USD 482 k | ﹤0.01% | 1651 |
|
|
2014
Q4 | USD 7.93 M | Comprar |
260,987
+39,819
| +18% | +USD 1.1 M | ﹤0.01% | 1628 |
|
|
2014
Q3 | USD 5.38 M | Comprar |
221,168
+19,492
| +10% | +USD 541 k | ﹤0.01% | 1883 |
|
|
2014
Q2 | USD 5.79 M | Comprar |
201,676
+29,056
| +17% | +USD 844 k | ﹤0.01% | 1860 |
|
|
2014
Q1 | USD 4.81 M | Vender |
172,620
-53,839
| -24% | -USD 1.48 M | ﹤0.01% | 1958 |
|
|
2013
Q4 | USD 5.92 M | Vender |
226,459
-29,846
| -12% | -USD 769 k | ﹤0.01% | 1883 |
|
|
2013
Q3 | USD 5.9 M | Vender |
256,305
-79,266
| -24% | -USD 1.95 M | ﹤0.01% | 1810 |
|
|
2013
Q2 | USD 8.76 M | Comprar |
+335,571
| Nuevas | +USD 9.7 M | ﹤0.01% | 1505 |
|
Otros fondos que tienen SBRA en su cartera
Posición de Invesco en SBRA: resumen de T2 2026
Invesco aumentó su participación en Sabra Healthcare REIT (SBRA) en 9.1% durante T2 2026, al comprar aproximadamente USD 4.18 M y elevar la posición a 2,532,046 acciones con un valor de USD 49.4 M. La posición representa ﹤0.01% de la cartera y ocupa el puesto #1118.
Invesco reportó por primera vez una posición en SBRA en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. Al cierre de T2 2026, 466 fondos que sigue Wall St. Rank mantienen una posición en SBRA.
- Al cierre de T2 2026, Invesco tenía 2,532,046 acciones de Sabra Healthcare REIT con un valor de USD 49.4 M.
- Invesco compró 210,907 acciones de Sabra Healthcare REIT en T2 2026, por un monto estimado de USD 4.18 M.
- Sabra Healthcare REIT representó ﹤0.01% de la cartera de Invesco en T2 2026 y fue su posición número 1118.
- Invesco reportó por primera vez una posición en Sabra Healthcare REIT en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- Al cierre de T2 2026, 466 fondos que sigue Wall St. Rank tenían Sabra Healthcare REIT en cartera.
Según el Informe 13F de Invesco correspondiente a T2 2026, presentado el 14 ago 2026.